Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0001430 (adenoma)
 21,222 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Since 1975 six cases with hepatic adenoma (5 females, 1 male) and five cases with focal nodular hyperplasia (3 females, 2 males) have been treated at our hospital. Four of the five women with hepatic adenoma took oral contraceptive pills before the diagnosis was made, only one patient took the pills in the group with focal nodular hyperplasia. Hepatic adenomas were resected electively in three patients; one patient underwent operation because of ruptureed adenoma with intraabdominal hemorrhage. In the other two cases with hepatic adenoma resections were not possible, but both tumors have regressed after the cessation of oral contraceptives. One patient in the group with focal nodular hyperplasia underwent liver resection because of intratumoral hemorrhage with recurrent pain; in the other four cases no treatment was done as symptoms were absent. We recommend elective resection for hepatic adenoma because of the high risk of spontaneous ruptur. Embolization or ligation of the hepatic artery are alternative procedures when resection is not possible and tumors do not regress after the cessation of oral contraceptives. On the other hand a more conservative attitude is suggested for focal nodular hyperplasia because those patients do not frequently bleed; resection is indicated in case of symptoms or growth of tumor.
 ...
PMID:[Management of liver cell adenoma and focal nodular hyperplasia]. 625 90

The case of a 37-year old woman with no previous pathology who developed liver adenoma and focal nodular hyperplasia after taking various oral contraceptive (OC) combined preparations over 15 years is described. The woman was hospitalized after discovery of a mass in the right hypochondrium. Other clinical findings were normal. During laparotomy 2 hepatic tumors were found: a mass 10 cm in diameter in the right lobe found at histological examination to be a focal nodular hyperplasia, and a mass 1 cm in diameter discovered fortuitously in the left lobe and which demonstrated the histological characteristics of a hepatic adenoma. The role of OCs in the development of hepatic adenomas is supported by epidemiological evidence, but the relationship between pills and focal nodular hyperplasia is much less clear. Although they occur in men and children, their development and the appearance of occasionally serious hemorrhagic complications appear to be encouraged by OCs. The complications are probably due to the vascular modifications observed in the tumor during OC use. The association of the 2 types of tumor in 1 patient has apparently been reported only once previously. Various hypotheses may be advanced to explain the occurrence.
 ...
PMID:[Association of hepatocellular adenoma and focal nodular hyperplasia of the liver in a woman on oral contraceptives]. 629 69

This article reports the case of a 38-year old woman with 2 hepatic adenomas associated with oral contraceptive (OC) use. At admission, the patient was seen with a hemoperitoneum caused by rupture of a hepatic adenoma of the right lobe. She was menstruating at the time of the onset of symptoms. During the postoperative course a 2nd adenoma of the contralateral lobe, not diagnosed during the earlier operation, ruptured. The patient has been taking OCs (1 mg norethindrone plus 0.08 mg mestranol) for 10 years, but had discontinued OC use 3 years prior to admission. The risk of hepatic adenomas associated with OC use increases with OC dose, duration of use, and age. Discontinuation of OC generally produces partial or complete regression of these tumors. However, this case suggests that hepatic adenoma in former OC users can present a high risk of rupture, especially during menstruation.
 ...
PMID:Rupture of multiple hepatic adenoma and oral contraceptive use: a case report. 667 96

Since the initial report in 1973 of 7 women who developed liver tumors while using oral contraceptives (OCs) over 300 cases have been reported. Hapatic tumors associated with OCs are benign (focal nodular hyperplasia or hepatocellular adenoma) or malignant (hepatocellular carcinoma, angiosarcoma, or cholangiocellular carcinoma). Mestranol is the main estrogen related to the development of hepatic adenoma but other OCs containing combinations of ethinyl estradiol, ethyl estradiol, mestranol, norethynodrel, norethisterone, and norgestrol are also associated with the tumors. Longterm OC users have an estimated annual incidence of 3-4/100,000. Hepatic tumors may present with abdominal pain or be an incidental finding on physical examination or at laparotomy. Diagnosis is confirmed by scintigraphy, echography, CT-scanning, angiography, or laparoscopy. Dynamic isotopic scanning may help differentiate between benign and malignant lesions. Symptomatic benign tumors and malignant tumors are best treated by partial hepatectomy and a ban on estrogens. The use of OCs should be forbidden following resections. Surgery is indicated for patients with persistent or recurrent pain, those with intraperitoneal hemorrhage and those in whom a carcinoma is suspected. The administration of synthetic estrogens to experimental animals results in a variety of morphological and functional changes within the hepatocyte. Other possibilities are that the estrogen potentiates the carcinogenicity of other compounds, either by changing their metabolism or by interfering with their excretion due to the cholestatic effects of synthetic estrogens.
 ...
PMID:Oral contraceptives and hepatic tumors. 708 79

The clinicopathological findings of eight children with hepatic adenoma in the absence of cirrhosis are presented. The lesions ranged in diameter from 0.1 to 14.5 cm. Associated disorders were Fanconi's anemia, type I glycogen storage disease. Hurler's disease, and severe combined immunodeficiency with ADA deficiency. The remaining three children had adenoma without known associated disorders. In the children with glycogenosis and Hurler's disease the adenomas were multiple. Significant dysplasia occurred in the two children with Fanconi's anemia; however, the lesions behaved in a benign fashion--one with regression of the tumor after cessation of androgen therapy and the other with nonrecurrence after complete resection. Proliferating cell nuclear antigen (PCNA) labeling index (LI) of the adenoma arising in patients with Fanconi's anemia was significantly greater than the PCNA-LI of adenoma in the other children (mean 4.1% versus 0.9% of nuclei), approaching the lower end of the spectrum for reported hepatocellular carcinoma cases. We emphasize that the worrisome pathology that may occur in hepatic adenoma in children, particularly with Fanconi's anemia, does not necessarily predict malignant behavior. The association of hepatic adenoma with Hurler's disease or severe combined immunodeficiency has not been reported previously.
 ...
PMID:Hepatic adenoma in the pediatric age group. Clinicopathological observations and assessment of cell proliferative activity. 757 76

This is a case report of a patient with hepatic adenoma who had a magnetic resonance imaging (MRI) appearance mimicking that of adenomatous hyperplasia. The adenoma was hyperintense on T1-weighted image (T1WI) and hypointense on T2-weighted image (T2WI). Pathologically, iron deposition in hepatocytes and Kupffer cells was proved by Prussian blue stain that caused hypointensity on T2WI. Iron deposition in hepatic adenomatous hyperplasia has been documented in the past, but there are no reports of siderotic adenoma in the literature. We suggest that siderotic hepatic adenoma be included in the differential diagnosis when MRI appearance is hyperintense on T1WI and hypointense on T2WI.
 ...
PMID:Magnetic resonance imaging of siderotic hepatic adenoma. 761 47

We report a case of a woman who showed hepatic and renal AA amyloidosis with a liver adenoma associated with the use of oral contraceptives. A nephrotic syndrome secondary to the renal amyloidosis underwent complete remission 7 years after the withdrawal of oral contraceptive therapy. Twenty-nine months after the initial presentation, the patient was admitted with acute upper abdominal pain and abdominal tenderness. The abdominal ultrasound revealed a subphrenic fluid collection, and a presumptive diagnosis of a ruptured hepatic adenoma was made. The liver adenoma diminished from 8 cm to 1 cm over a 13-year follow up after the discontinuance of oral contraceptive therapy.
 ...
PMID:Systemic AA amyloidosis induced by oral contraceptive-associated hepatocellular adenoma: a 13-year follow up. 767 44

Neoplastic data on 1370 control Wistar rats from 10 carcinogenicity bioassays done between 1980 and 1990 were reviewed. Mean percentage survival at 104 weeks was 58% for males and 59% for females. A total of 1857 neoplasms were diagnosed in 466 (68%) male and 582 (85%) female rats; 1390 were benign and 467 were malignant (12% with metastasis). Seventy-four percent of all neoplasms were in endocrine and reproductive systems. Most common neoplasms (affecting more than 7% of either sex) were pituitary adenoma (27.7% males; 55.0% females), mammary fibroadenoma (1.0% males; 25.3% females), mammary adenocarcinoma (1.0% males; 13.1% females), adrenal cortical adenoma (8.3% males; 9.3% females), and endometrial stromal polyp (9.6% females). Fourteen neoplasms affecting 2 to 6% of either sex included adrenal pheochromocytoma, thyroid C cell adenoma, thyroid follicular adenoma, pancreatic islet cell adenoma, lymphoma, histiocytic sarcoma, thymoma, hepatic adenoma, pancreatic acinar adenoma, mammary adenoma, dermal fibroma, astrocytoma, testicular interstitial cell tumor, and ovarian granulosa cell tumor. Remaining neoplasms were seen in less than 2% of animals.
 ...
PMID:Spontaneous neoplasms in control Wistar rats. 812 15

Forty-one patients (16 females and 25 males) over 10 years of age from five different European centres were studied retrospectively. Of those patients 19 were below the 3rd percentile for height. Hypoglycaemia was still reported in 6 patients. Hepatomegaly was present in 39 out of 40, while 11 out of 27 reported patients had marked hepatomegaly (> 10 cm below the costal margin in the midclavicular line). Adenomas were detected in 11 out of 39 patients, alpha-1-fetoprotein was reported to be within normal limits in a total of 22 patients of whom 6 had adenomas. Blood cholesterol concentration was elevated in 31 out of 38 patients, in 7 greater than 10.0 mmol/l. Blood triglycerides were elevated in 29 out of 34 patients, in 8 patients greater than 4.0 mmol/l. Blood uric acid concentration was elevated in 19 out of 35 patients, 12 of them being treated with allopurinol. Mental development was reported to be normal in 32 out of 37 patients. Since limited information on treatment was available no significant differences between treatment groups could be detected. In order to evaluate the effect of treatment, 20 patients (10 females and 10 males) of one centre were studied before and after at least 5 years of treatment. This treatment consisted of frequent feedings during the day together with nocturnal gastric drip feeding. Patients were divided into responders (n = 16) and non-responders (n = 4) depending on their (change in) SDS (standard deviation score) for height. Liver adenomas were detected in 3 patients, of which one was a non-responder. Alpha-fetoprotein was normal in all patients.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:The long-term outcome of patients with glycogen storage disease type Ia. 831 26

Hepatic adenoma and focal nodular hyperplasia are unfrequent benign lesions of the liver with individual histologic characteristics, but not always clinically distinguishable. The main difference is the intratumoral or intraperitoneal bleeding risk (high in adenoma and virtually zero in focal nodular hyperplasia). Surgery is the elective treatment for the first, while a more conservative attitude is allowed for the second. We present the case of a woman with an hepatic mass that clinically and radiologically seemed to be an adenoma. An atypical hepatectomy was done uneventfully. The examination of the specimen showed shaw focal nodular hyperplasia. We review the diagnostic and therapeutic controversy between these entities, because only the histologic examination of the entire surgical specimen could demonstrate the real nature of the lesion.
 ...
PMID:[Hepatic adenoma and focal nodular hyperplasia: difficult differential diagnosis. Presentation of a case of focal nodular hyperplasia]. 892 31


<< Previous 1 2 3 4 5 6 7 Next >>